NCI Cancer News

Syndicate content National Cancer Institute
The latest cancer news from the U.S. government's principal agency for cancer research.
Updated: 1 min 7 sec ago

NCI’s Douglas R. Lowy and John T. Schiller to receive 2017 Lasker Award

Tue, 09/05/2017 - 23:00

Dr. Douglas R. Lowy and Dr. John T. Schiller of the National Cancer Institute receive the 2017 Lasker-DeBakey Clinical Medical Research Award for their significant research leading to the development of HPV vaccines.

Categories: NCI News

NCI study identifies essential genes for cancer immunotherapy

Sun, 08/06/2017 - 23:00

A new NCI study identifies genes in cancer cells that are necessary for them to be killed by T cells, and therefore could be partially responsible for why immunotherapy doesn’t work in some patients.

Categories: NCI News

NCI study shows feasibility of cancer screening protocol for patients with Li-Fraumeni syndrome

Wed, 08/02/2017 - 23:00

A new NCI study demonstrates the feasibility of a comprehensive screening protocol for patients with Li-Fraumeni syndrome, a rare inherited disorder that leads to a higher risk of developing certain cancers.

Categories: NCI News

NCI-COG Pediatric MATCH trial to test targeted drugs in childhood cancers

Sun, 07/23/2017 - 23:00

The nationwide precision medicine trial will enroll children and adolescents with advanced cancers that haven’t responded to standard therapy to explore treatments targeted at specific genetic mutations.

Categories: NCI News

TCGA study of liver cancer reveals potential targets for therapy

Wed, 06/14/2017 - 23:00

Only two drugs are FDA-approved for liver cancer. This study of hepatocellular carcinoma found genetic alterations in tumors—including mutations in tumor-suppressing genes and high expression of immune checkpoint genes—that could be targets for drugs that already exist.

Categories: NCI News